KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Sep 09, 2020 $1.75 $1.84 $1.70 $1.79 341 441
Sep 08, 2020 $1.58 $1.72 $1.53 $1.71 283 375
Sep 04, 2020 $1.71 $1.73 $1.45 $1.60 946 226
Sep 03, 2020 $1.85 $1.86 $1.70 $1.71 786 149
Sep 02, 2020 $1.94 $1.94 $1.81 $1.84 704 242
Sep 01, 2020 $2.02 $2.03 $1.89 $1.93 992 046
Aug 31, 2020 $1.93 $1.96 $1.88 $1.94 487 427
Aug 28, 2020 $1.88 $1.95 $1.83 $1.92 413 321
Aug 27, 2020 $1.92 $1.97 $1.73 $1.91 1 424 407
Aug 26, 2020 $1.90 $1.97 $1.86 $1.90 402 945
Aug 25, 2020 $1.95 $2.03 $1.86 $1.91 957 065
Aug 24, 2020 $2.18 $2.18 $1.85 $1.90 2 107 918
Aug 21, 2020 $2.49 $2.50 $2.15 $2.18 4 651 752
Aug 20, 2020 $2.29 $2.29 $2.18 $2.21 378 137
Aug 19, 2020 $2.31 $2.39 $2.26 $2.30 200 426
Aug 18, 2020 $2.44 $2.45 $2.27 $2.35 305 255
Aug 17, 2020 $2.28 $2.49 $2.21 $2.43 814 769
Aug 14, 2020 $2.33 $2.44 $2.19 $2.24 910 978
Aug 13, 2020 $2.16 $2.22 $2.10 $2.15 406 739
Aug 12, 2020 $2.23 $2.27 $2.10 $2.15 374 290
Aug 11, 2020 $2.35 $2.36 $2.16 $2.23 485 530
Aug 10, 2020 $2.40 $2.44 $2.37 $2.42 258 573
Aug 07, 2020 $2.26 $2.47 $2.25 $2.44 707 337
Aug 06, 2020 $2.39 $2.48 $2.24 $2.33 728 130
Aug 05, 2020 $2.56 $2.63 $2.48 $2.60 546 678
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT